e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary circulation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The adverse effect of estrogen on bone morphogenetic protein receptor (BMPR) signal pathway in pulmonary arterial endothelial cells (PAEC)
H. Ichimori, S. Kogaki, H. Ishida, J. Narita, T. Uchikawa, S. Maekawa, S. Matsumoto, Y. Okada, K. Ozono (Suita, Japan)
Source:
Annual Congress 2009 - Pulmonary circulation II
Session:
Pulmonary circulation II
Session type:
Thematic Poster Session
Number:
3920
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ichimori, S. Kogaki, H. Ishida, J. Narita, T. Uchikawa, S. Maekawa, S. Matsumoto, Y. Okada, K. Ozono (Suita, Japan). The adverse effect of estrogen on bone morphogenetic protein receptor (BMPR) signal pathway in pulmonary arterial endothelial cells (PAEC). Eur Respir J 2009; 34: Suppl. 53, 3920
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017
Year: 2017
Bone morphogenetic proteins (BMPs) inhibit hypoxia stimulated human pulmonary artery fibroblast (PAF) proliferation via inhibition of p38 MAP kinase and HIF-1α
Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Year: 2004
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension
Source: Eur Respir J 2009; 34: 1100-1110
Year: 2009
Sphingosine-1-phosphate receptor 1 controls endothelial cells permeability and function through the Bone morphogenetic 9/Endoglin signaling pathway.
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Mutations in the bone morphogenic protein receptor 2 promoter in heritable pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
The microRNA cluster 17/92 regulates the expression of the bone morphogenetic protein receptor type II involved in the pathogenesis of pulmonary hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Expression of bradykinin B2 receptor (B2R) and vascular endothelial growth factor (VEGF) in asthma and COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007
ErbB receptor regulation by dexamethasone in mouse type II epithelial cells
Source: Eur Respir J 2006; 28: 1117-1123
Year: 2006
Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004
Caveolin-1 regulation of thrombin signalling in endothelial cells
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007
Oral presentation: The bone morphogenetic protein antagonist Gremlin in pulmonary hypertension
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
IL18 induces p38 MAP kinase activation and adhesion capacities in BMPRII knocked down human lung microvascular endothelial cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept